These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 23999871)

  • 1. Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics.
    Kalani A; Tyagi A; Tyagi N
    Mol Neurobiol; 2014 Feb; 49(1):590-600. PubMed ID: 23999871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
    Jarmalavičiūtė A; Pivoriūnas A
    Pharmacol Res; 2016 Nov; 113(Pt B):816-822. PubMed ID: 26855317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases.
    Nouri Z; Barfar A; Perseh S; Motasadizadeh H; Maghsoudian S; Fatahi Y; Nouri K; Yektakasmaei MP; Dinarvand R; Atyabi F
    J Nanobiotechnology; 2024 Aug; 22(1):463. PubMed ID: 39095888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes for targeted siRNA delivery across biological barriers.
    El Andaloussi S; Lakhal S; Mäger I; Wood MJ
    Adv Drug Deliv Rev; 2013 Mar; 65(3):391-7. PubMed ID: 22921840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes: Natural Carriers for siRNA Delivery.
    Kumar L; Verma S; Vaidya B; Gupta V
    Curr Pharm Des; 2015; 21(31):4556-65. PubMed ID: 26486142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologically activated therapeutics for neuroprotection.
    Lipton SA
    Nat Rev Neurosci; 2007 Oct; 8(10):803-8. PubMed ID: 17882256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
    Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
    J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Exosomes in Stemness and Neurodegenerative Diseases-Chemoresistant-Cancer Therapeutics and Phytochemicals.
    Beeraka NM; Doreswamy SH; Sadhu SP; Srinivasan A; Pragada RR; Madhunapantula SV; Aliev G
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine.
    Koppers-Lalic D; Hogenboom MM; Middeldorp JM; Pegtel DM
    Adv Drug Deliv Rev; 2013 Mar; 65(3):348-56. PubMed ID: 22820525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as CNS Drug Targets.
    Gurwitz D
    Drug Dev Res; 2016 Nov; 77(7):331-335. PubMed ID: 27569840
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes as drug delivery systems: A brief overview and progress update.
    Patil SM; Sawant SS; Kunda NK
    Eur J Pharm Biopharm; 2020 Sep; 154():259-269. PubMed ID: 32717385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage and Passage Dependent Neuroprotective Effects of Exosomes Derived from Rat Bone Marrow Mesenchymal Stem Cells: An In Vitro Analysis.
    Venugopal C; Shamir C; Senthilkumar S; Babu JV; Sonu PK; Nishtha KJ; Rai KS; K S; Dhanushkodi A
    Curr Gene Ther; 2017; 17(5):379-390. PubMed ID: 29366415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases.
    Lo Van A; Sakayori N; Hachem M; Belkouch M; Picq M; Lagarde M; Osumi N; Bernoud-Hubac N
    Biochimie; 2016 Nov; 130():163-167. PubMed ID: 27496085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes: natural nanoparticles as bio shuttles for RNAi delivery.
    Darband SG; Mirza-Aghazadeh-Attari M; Kaviani M; Mihanfar A; Sadighparvar S; Yousefi B; Majidinia M
    J Control Release; 2018 Nov; 289():158-170. PubMed ID: 30290245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124.
    Song Y; Li Z; He T; Qu M; Jiang L; Li W; Shi X; Pan J; Zhang L; Wang Y; Zhang Z; Tang Y; Yang GY
    Theranostics; 2019; 9(10):2910-2923. PubMed ID: 31244932
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased Microglial Exosomal miR-124-3p Alleviates Neurodegeneration and Improves Cognitive Outcome after rmTBI.
    Ge X; Guo M; Hu T; Li W; Huang S; Yin Z; Li Y; Chen F; Zhu L; Kang C; Jiang R; Lei P; Zhang J
    Mol Ther; 2020 Feb; 28(2):503-522. PubMed ID: 31843449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?
    Correia SC; Moreira PI
    J Neurochem; 2010 Jan; 112(1):1-12. PubMed ID: 19845827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes and their Application in Biomedical Field: Difficulties and Advantages.
    Rezaie J; Ajezi S; Avci ÇB; Karimipour M; Geranmayeh MH; Nourazarian A; Sokullu E; Rezabakhsh A; Rahbarghazi R
    Mol Neurobiol; 2018 Apr; 55(4):3372-3393. PubMed ID: 28497202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.